Spertus et al identified risk factors for poor compliance by a patient prescribed a thienopyridine following placement of a drug-eluted stent. Failure to continue thienopyridine therapy is associated with significant complications. The authors are from multiple universities participating in the Cardiovascular Outcomes Research Consortium (CORC).